Literature DB >> 816480

A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines.

G C Schild, J M Wood, R W Newman.   

Abstract

Single-radial-diffusion techniques are proposed as possible alternatives to tests based on agglutination of erythrocytes for the assay of the haemagglutinin content of influenza vaccines. Two test procedures (microtest and macrotest) and the use of reference reagents to assay vaccines using these tests are described. The two tests are of similar reproducibility and accuracy but the macrotest is technically simpler to perform and results of assays may be obtained more rapidly.

Mesh:

Substances:

Year:  1975        PMID: 816480      PMCID: PMC2366365     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  Crystalline antigen from the influenza virus envelope.

Authors:  C M Brand; J J Skehel
Journal:  Nat New Biol       Date:  1972-08-02

4.  One-step growth curve of Western equine encephalomyelitis virus on chicken embryo cells grown in vitro and analysis of virus yields from single cells.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  4 in total
  26 in total

1.  The relative immunogenicity in mice of whole and split influenza virus.

Authors:  S S Gandhi
Journal:  J Hyg (Lond)       Date:  1978-12

2.  Bringing influenza vaccines into the 21st century.

Authors:  Ethan C Settembre; Philip R Dormitzer; Rino Rappuoli
Journal:  Hum Vaccin Immunother       Date:  2013-12-30       Impact factor: 3.452

3.  Preparation and properties of a novel influenza subunit vaccine.

Authors:  H Bachmayer; E Liehl; G Schmidt
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

4.  Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.

Authors:  Gale E Smith; Xiangjie Sun; Yaohui Bai; Ye V Liu; Michael J Massare; Melissa B Pearce; Jessica A Belser; Taronna R Maines; Hannah M Creager; Gregory M Glenn; David Flyer; Peter Pushko; Min Z Levine; Terrence M Tumpey
Journal:  Virology       Date:  2017-06-16       Impact factor: 3.616

5.  Relative antigenicity in mice of H1N1, H3N2 and B strains present in inactivated influenza virus vaccines.

Authors:  M L Profeta; M Ruggeri
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

6.  A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.

Authors:  A Goodeve; C W Potter; A Clark; R Jennings; G C Schild; R Yetts
Journal:  J Hyg (Lond)       Date:  1983-02

7.  Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.

Authors:  Hae Jung Han; Min-Suk Song; Su-Jin Park; Han Yeul Byun; Norbert John C Robles; Suk-Hoon Ha; Young Ki Choi
Journal:  J Microbiol       Date:  2019-01-31       Impact factor: 3.422

8.  A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

Authors:  Victor C Huber; Paul G Thomas; Jonathan A McCullers
Journal:  Vaccine       Date:  2009-01-07       Impact factor: 3.641

9.  A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.

Authors:  A Clark; C W Potter; R Jennings; J P Nicholl; A F Langrick; G C Schild; J M Wood; D A Tyrrell
Journal:  J Hyg (Lond)       Date:  1983-06

10.  Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.

Authors:  C W Potter; R Jennings; K Nicholson; D A Tyrrell; K G Dickinson
Journal:  J Hyg (Lond)       Date:  1977-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.